IL-1 Acts Directly on CD4 T Cells to Enhance Their Antigen-driven Expansion and Differentiation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2009 Apr 11

PMID 19359475

Citations 317

Authors

Shlomo Z Ben-Sasson

Jane Hu-Li

Juan Quiel

Stephane Cauchetaux

Maya Ratner

Ilana Shapira

Charles A Dinarello

William E Paul

Affiliations

Soon will be listed here.

Abstract

IL-1 causes a marked increase in the degree of expansion of naïve and memory CD4 T cells in response to challenge with their cognate antigen. The response occurs when only specific CD4 T cells can respond to IL-1beta, is not induced by a series of other cytokines and does not depend on IL-6 or CD-28. When WT cells are primed in IL-1R1(-/-) recipients, IL-1 increases the proportion of cytokine-producing transgenic CD4 T cells, especially IL-17- and IL-4-producing cells, strikingly increases serum IgE levels and serum IgG1 levels. IL-1beta enhances antigen-mediated expansion of in vitro primed Th1, Th2, and Th17 cells transferred to IL-1R1(-/-) recipients. The IL-1 receptor antagonist diminished responses to antigen plus lipopolysaccharide (LPS) by approximately 55%. These results indicate that IL-1beta signaling in T cells markedly induces robust and durable primary and secondary CD4 responses.

Citing Articles

Progress in African Swine Fever Vector Vaccine Development.

Yang Y, Yuan H, Zhang Y, Luan J, Wang H Int J Mol Sci. 2025; 26(3).

PMID: 39940691 PMC: 11816837. DOI: 10.3390/ijms26030921.

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges.

Wang M, Yu F, Zhang Y Mol Cancer. 2025; 24(1):26.

PMID: 39827147 PMC: 11748575. DOI: 10.1186/s12943-024-02214-5.

Tissue-resident immune cells: from defining characteristics to roles in diseases.

Li J, Xiao C, Li C, He J Signal Transduct Target Ther. 2025; 10(1):12.

PMID: 39820040 PMC: 11755756. DOI: 10.1038/s41392-024-02050-5.

Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors.

Orehek S, Ramuta T, Lainscek D, Malensek S, Sala M, Bencina M Nat Commun. 2024; 15(1):10801.

PMID: 39737979 PMC: 11686184. DOI: 10.1038/s41467-024-55083-3.

The Potential of a Novel Cold Atmospheric Plasma Jet as a Feasible Therapeutic Strategy for Gingivitis-A Cell-Based Study.

Negrescu A, Zampieri L, Martines E, Cimpean A Cells. 2024; 13(23).

PMID: 39682721 PMC: 11640168. DOI: 10.3390/cells13231970.

References

Newton R, Uhl J, COVINGTON M, Back O . The distribution and clearance of radiolabeled human interleukin-1 beta in mice. Lymphokine Res. 1988; 7(3):207-16. View

Pape K, Khoruts A, Mondino A, Jenkins M . Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J Immunol. 1997; 159(2):591-8. View

Koziczak-Holbro M, Joyce C, Gluck A, Kinzel B, Muller M, Tschopp C . IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression. J Biol Chem. 2007; 282(18):13552-60. DOI: 10.1074/jbc.M700548200. View

Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nel A . The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol. 2000; 165(4):1743-54. DOI: 10.4049/jimmunol.165.4.1743. View

Chung D, Kasper D, Panzo R, Chitnis T, Grusby M, Sayegh M . CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003; 170(4):1958-63. DOI: 10.4049/jimmunol.170.4.1958. View

Zwijnenburg P, van der Poll T, Florquin S, Roord J, Marceline van Furth A . IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis. J Immunol. 2003; 170(9):4724-30. DOI: 10.4049/jimmunol.170.9.4724. View

Rochman I, Paul W, Ben-Sasson S . IL-6 increases primed cell expansion and survival. J Immunol. 2005; 174(8):4761-7. DOI: 10.4049/jimmunol.174.8.4761. View

Varga S, Welsh R . Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus. J Immunol. 1998; 161(7):3215-8. View

Guo Z, Zhang M, An H, Chen W, Liu S, Guo J . Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways. Blood. 2003; 102(13):4441-7. DOI: 10.1182/blood-2002-11-3420. View

10.

Helmby H, Grencis R . Interleukin 1 plays a major role in the development of Th2-mediated immunity. Eur J Immunol. 2004; 34(12):3674-81. DOI: 10.1002/eji.200425452. View

11.

Kishimoto T . The biology of interleukin-6. Blood. 1989; 74(1):1-10. View

12.

Bendele A, Sennello G, McAbee T, Frazier J, Chlipala E, Rich B . Effects of interleukin 1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats. J Rheumatol. 1999; 26(6):1225-9. View

13.

Acosta-Rodriguez E, Napolitani G, Lanzavecchia A, Sallusto F . Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007; 8(9):942-9. DOI: 10.1038/ni1496. View

14.

Khader S, Bell G, Pearl J, Fountain J, Rangel-Moreno J, Cilley G . IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007; 8(4):369-77. DOI: 10.1038/ni1449. View

15.

Ku C, von Bernuth H, Picard C, Zhang S, Chang H, Yang K . Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007; 204(10):2407-22. PMC: 2118442. DOI: 10.1084/jem.20070628. View

16.

Schmitz N, Kurrer M, Bachmann M, Kopf M . Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol. 2005; 79(10):6441-8. PMC: 1091664. DOI: 10.1128/JVI.79.10.6441-6448.2005. View

17.

Gelman A, LaRosa D, Zhang J, Walsh P, Choi Y, Sunyer J . The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity. 2006; 25(5):783-93. PMC: 2840381. DOI: 10.1016/j.immuni.2006.08.023. View

18.

Aujla S, Chan Y, Zheng M, Fei M, Askew D, Pociask D . IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med. 2008; 14(3):275-81. PMC: 2901867. DOI: 10.1038/nm1710. View

19.

Luft T, Jefford M, Luetjens P, Hochrein H, Masterman K, Maliszewski C . IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. J Immunol. 2002; 168(2):713-22. DOI: 10.4049/jimmunol.168.2.713. View

20.

Badovinac V, Mostarica-Stojkovic M, Dinarello C, Stosic-Grujicic S . Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J Neuroimmunol. 1998; 85(1):87-95. DOI: 10.1016/s0165-5728(98)00020-4. View